The company is pleased to report positive performances from all divisions this quarter. Growth in our research divisions, Discovery Services and the Dedicated Centres was solid
The AGE1.CR.pIX cell line is derived from primary cells of a duck embryo and was designed to comply with health authority guidelines
The issue with a face value of Rs 10 per equity share consists of a fresh issue of equity shares worth up to Rs 400 crore
The company will not receive any proceeds from the offer as all of it will go to the promoter selling shareholder.
Connectivity and harmonisation were both key driving factors behind our decision to choose the CARA Life Sciences Platform to consolidate our processes
India is working towards augmenting health infrastructure and have initiated multiple schemes to strengthen health systems and improve health service delivery
This DSIR recognition for company's in-house R&D Unit make it eligible for receiving funds for R&D purpose from various government departments and agencies
Launch of Apollo Genomics Institutes would provide genetic counselling, tests, treatment and care for genetic disorders
Palbociclib has a unique mechanism of action which helps in delaying disease progression when co-administered with hormonal therapies
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
Subscribe To Our Newsletter & Stay Updated
